Evidence map›Paper›PMID 29108965›Full record

ArticleThe Journal of allergy and clinical immunology2018

IL-1/inhibitory κB kinase ε-induced glycolysis augment epithelial effector function and promote allergic airways disease.

Xi Qian, Reem Aboushousha, Cheryl van de Wetering, Shi B Chia, Eyal Amiel, Robert W Schneider, Jos L J van der Velden, Karolyn G Lahue, Daisy A Hoagland, Dylan T Casey and 19 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Dysregulation of PKM2 promotes inflammatory response in allergic rhinitis.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 4 institutions in 3 countries.

Xi QianDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Reem AboushoushaDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Cheryl van de WeteringDepartment of Pulmonology, Maastricht University Medical Center, Maastricht, The Netherlands.
Shi B ChiaDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Eyal AmielDepartment of Medical Laboratory and Radiation, University of Vermont College of Nursing and Health Sciences, Burlington, Vt.
Robert W SchneiderDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Jos L J van der VeldenDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Karolyn G LahueDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Daisy A HoaglandDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Dylan T CaseyDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Nirav DaphtaryDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Jennifer L AtherDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Matthew J RandallDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Minara AliyevaDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Kendall E BlackDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
David G ChapmanDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt; Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney, Sydney, Australia.
Lennart K A LundbladDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
David H McMillanDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Anne E DixonDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Vikas AnathyDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Charles G IrvinDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Matthew E PoynterDepartment of Medicine, University of Vermont College of Medicine, Burlington, Vt.
Emiel F M WoutersDepartment of Pulmonology, Maastricht University Medical Center, Maastricht, The Netherlands.
Pamela M VacekMedical Biostatistics Unit, University of Vermont College of Medicine, Burlington, Vt.
Monique HenketDepartment of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
Florence SchleichDepartment of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
Renaud LouisDepartment of Respiratory Medicine, CHU Sart-TilmanB35, Liege, Belgium.
Albert van der VlietDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt.
Yvonne M W Janssen-HeiningerDepartment of Pathology and Laboratory Medicine, University of Vermont College of Medicine, Burlington, Vt. Electronic address: yvonne.janssen@uvm.edu.
University of Vermont · USMaastricht University · NLUniversity of Vermont Medical Center · USWoolcock Institute of Medical Research · AU

Funding

VERMONT IMMUNOBIOLOIGY/ INFECTIOUS DISEASES CENTERP20RR021905 · NCRR · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MATTHEWS, DWIGHT E · 2006 to 2011
$14.5M
Vermont Immunobioloigy/ Infectious Diseases CenterP20GM103496 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2012 to 2015
$8.7M
Vermont Immunology/Infectious Diseases CenterP30GM118228 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BUDD, RALPH C · 2016 to 2021
$6.8M
S-glutathionylation chemistry in fibrotic lung remodelingR35HL135828 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2017 to 2023
$6.5M
Multidisciplinary Training in Lung BiologyT32HL076122 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI IRVIN, CHARLES G, POYNTER, MATTHEW E · 2004 to 2023
$6.1M
REGULATION OF NFKB IN LUNG EPITHELIUM BY ROS/RNSR01HL060014 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 1999 to 2016
$5.9M
Dual Oxidase in Airway Epithelial Repair and RemodelingR01HL085646 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2008 to 2020
$4.7M
Redox-based Fas Signaling in Allergic Airway DiseaseR01HL079331 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI JANSSEN-HEININGER, YVONNE M. W. · 2005 to 2016
$4.2M
Obese Allergic Asthma and the Impact of Weight Loss on Airway Epithelial FunctionR01HL133920 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI DIXON, ANNE E, POYNTER, MATTHEW E · 2016 to 2020
$3.9M
Translational Research in Lung Biology and DiseaseP30GM103532 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI IRVIN, CHARLES G · 2012 to 2016
$3.7M
Endoplasmic Reticulum Stress Signaling in Allergen-induced Airway RemodelingR01HL122383 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI ANATHY, VIKAS · 2015 to 2023
$3.5M
Non-Allergic Late-Onset Asthma of Obesity: Pathophysiology and TherapyR01HL130847 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI BATES, JASON HT, DIXON, ANNE E · 2016 to 2019
$2.3M
NCRR NIH HHS P20 RR021905NHLBI NIH HHS R01 HL060014NHLBI NIH HHS R01 HL079331NHLBI NIH HHS R01 HL085646NHLBI NIH HHS R01 HL122383NHLBI NIH HHS R01 HL130847NHLBI NIH HHS R01 HL133920NHLBI NIH HHS R01 HL137268NHLBI NIH HHS R01 HL138708NHLBI NIH HHS R01 HL142081NHLBI NIH HHS R35 HL135828NHLBI NIH HHS T32 HL076122NIAID NIH HHS R21 AI112804NIA NIH HHS R21 AG055325NIEHS NIH HHS R01 ES021476NIGMS NIH HHS P20 GM103496NIGMS NIH HHS P30 GM103532NIGMS NIH HHS P30 GM118228
6 · The paper itself

Abstract

backgroundEmerging studies suggest that enhanced glycolysis accompanies inflammatory responses. Virtually nothing is known about the relevance of glycolysis in patients with allergic asthma.

objectivesWe sought to determine whether glycolysis is altered in patients with allergic asthma and to address its importance in the pathogenesis of allergic asthma.

methodsWe examined alterations in glycolysis in sputum samples from asthmatic patients and primary human nasal cells and used murine models of allergic asthma, as well as primary mouse tracheal epithelial cells, to evaluate the relevance of glycolysis.

resultsIn a murine model of allergic asthma, glycolysis was induced in the lungs in an IL-1-dependent manner. Furthermore, administration of IL-1β into the airways stimulated lactate production and expression of glycolytic enzymes, with notable expression of lactate dehydrogenase A occurring in the airway epithelium. Indeed, exposure of mouse tracheal epithelial cells to IL-1β or IL-1α resulted in increased glycolytic flux, glucose use, expression of glycolysis genes, and lactate production. Enhanced glycolysis was required for IL-1β- or IL-1α-mediated proinflammatory responses and the stimulatory effects of IL-1β on house dust mite (HDM)-induced release of thymic stromal lymphopoietin and GM-CSF from tracheal epithelial cells. Inhibitor of κB kinase ε was downstream of HDM or IL-1β and required for HDM-induced glycolysis and pathogenesis of allergic airways disease. Small interfering RNA ablation of lactate dehydrogenase A attenuated HDM-induced increases in lactate levels and attenuated HDM-induced disease. Primary nasal epithelial cells from asthmatic patients intrinsically produced more lactate compared with cells from healthy subjects. Lactate content was significantly higher in sputum supernatants from asthmatic patients, notably those with greater than 61% neutrophils. A positive correlation was observed between sputum lactate and IL-1β levels, and lactate content correlated negatively with lung function.

conclusionsCollectively, these findings demonstrate that IL-1β/inhibitory κB kinase ε signaling plays an important role in HDM-induced glycolysis and pathogenesis of allergic airways disease.

Indexed as

AnimalsAntigens, DermatophagoidesAsthmaCells, CulturedCohort StudiesDisease Models, AnimalFemaleGlycolysisHumansHypersensitivityI-kappa B ProteinsInterleukin-1betaLactic AcidLungMaleMiceAntigens, DermatophagoidesI-kappa B ProteinsInterleukin-1betaLactic AcidNFKBIE protein, humanProto-Oncogene ProteinsRNA, Small InterferingAsthmaglycolysishouse dust miteIL-1inhibitor of κB kinase εlactatelactate dehydrogenase A

Identifiers

PMID29108965
PMCPMC6278819
OpenAlexW2766704960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.